Topics covered include: the global market in a historical context; and the outlook of "macro misery", having regard to unemployment, inflation, and the likelihood of recession and tighter monetary policy.
Copyright 2022 – Finance News Network
Source: Finance News Network
08 Jul 2021 - ImpediMed Limited (ASX:IPD) CEO and Managing Director Richard Carreon discusses the company's bioimpedance spectroscopy platform SOZO, which is particularly targeted at noninvasive clinical assessment and monitoring of fluid status and tissue composition in the treatment of secondary lymphoedema, heart failure and renal failure.
Read More08 Dec 2023 - Stealth Global Holdings reports record FY23 results, driven by efficient consolidation, organic growth, and prudent financial management. CEO Mike Arnold reveals plans for further expansion, M&A, and a commitment to dividends in FY24.
Read More06 Mar 2024 - Arrow Minerals (ASX:AMD) Managing Director David Flanagan provides introduction to the company, discussing the companies Simandou North Iron Project in West Africa.
Read More10 Sep 2019 - Cashwerkz Limited (ASX:CWZ) Director, John Nantes talks FY19 results and outlook, including growth in distribution through adviser platforms, neo-banks and new functionality.
Read More20 Nov 2023 - ABX Group (ASX:ABX) Managing Director Mark Cooksey speaks about rare earth resources, advancing sustainable aluminum production with promising growth for investors in the coming months.
Read More12 Oct 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the FDA fast track designation received in first-line non-small cell lung cancer, the company's new Phase 2 trial in soft tissue sarcoma and the outlook ahead.
Read More10 Mar 2025 - Addressing Chronic Conditions with Targeted Treatments
Read More01 Apr 2022 - Lepidico Limited (ASX:LPD) Managing Director Joe Walsh discusses the progress of the company's Karibib lithium operations and Abu Dhabi processing plant, potential capital raisings and offtake agreements.
Read More07 Nov 2023 - Elementos Limited (ASX:ELT) Managing Director Joe David provides an update on the company's tin projects in Tasmania and Spain.
Read More02 Oct 2019 - Noxopharm Limited (ASX:NOX) Founder and Executive Chairman, Dr Graham Kelly, discusses early results on the use of Noxopharm's lead drug candidate, Veyonda, for the treatment of prostate cancer.
Read More
